Pelthos Therapeutics Inc (PTHS)

$21.28 +0.32 (1.50%)
Market Cap 13.59M
Revenue (ttm) 0.00
Net Income (ttm) -7.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.60
Volume 5,339
Avg Vol 76,229
Day's Range N/A - N/A
Shares Out 649,000.00
Stochastic %K 89%
Beta 3.88
Analysts Strong Buy
Price Target $60.00

Company Profile

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeu...

Industry: Biotechnology
Sector: Healthcare
Phone: 877 265 8266
Address:
4020 Stirrup Creek Drive, Suite 110, Durham, United States
Jwa68
Jwa68 Aug. 15 at 11:10 PM
$PTHS 25, 2025, following an inquest held before the court regarding the Company’s damages, the court entered an order (i) holding that the Company (identified in the order as Chromocell Therapeutics Corporation) is entitled to damages against Mr. Kopfli and Chromocell Corporation, jointly and severally, in the amount of $17,950,205.38, as well as additional damages against Mr. Kopfli in the amount of $348,461, and (ii) directing entry of judgment in the Company’s favor for those amounts, accordingly
0 · Reply
Bigmal1
Bigmal1 Aug. 15 at 1:43 PM
$PTHS PT $50
1 · Reply
Jwa68
Jwa68 Aug. 14 at 1:06 AM
$PTHS They just received an $18M judgement in their favor that dates back long before the merger. Shares are cheap here. 600k float will again soon be found the momentum crowd. Just need a very small spark.
1 · Reply
yourwifesbf69
yourwifesbf69 Aug. 13 at 11:05 PM
$PTHS During the three and six months ended June 30, 2025, the Company had a net loss of approximately $3.5 million and $5.4 million, respectively. As of June 30, 2025, the Company has cash of approximately $0.1 million and a working capital deficit $6.5 million. Based on the Company’s current projections, management believes there is substantial doubt about its ability to continue to operate as a going concern and fund its operations through at least the next twelve months following the issuance of these condensed consolidated financial statements. While the Company completed an equity offering of $50.1 million subsequent to the end of the reporting period, the Company expects that costs associated with the commercial launch of Zelsuvmi ),
1 · Reply
Slapshot22
Slapshot22 Aug. 13 at 10:11 PM
$PTHS Q2 10-Q earnings posted on corp site IR under earnings. Will have to read in depth when not on phone. GLA.
0 · Reply
PBRider
PBRider Aug. 11 at 4:50 PM
$PTHS anyone know when we can expect earnings? Now with first and only product on market, this should soar...
1 · Reply
Zergg
Zergg Aug. 8 at 7:55 PM
$PTHS i think i was early with my last post but i don’t believe im wrong on value. I would put this hitting 100 around Q4 earnings at this point. Once the new product launch is on the wrap sheet.
1 · Reply
Jwa68
Jwa68 Aug. 8 at 7:09 PM
$PTHS Cheap again. Likely good for another trade with the miniscule share coint sub 1m
0 · Reply
DarthGoat
DarthGoat Aug. 8 at 2:02 PM
$CGTX $ELPW $ENGS $PTHS $WOLF You placed orders on July 8 using my EPEC data published on Substack — here’s the profit you could have made as of August 8 by simply placing buy orders after the market opened. To get this link, just email me at [email protected].
0 · Reply
Tgk11
Tgk11 Aug. 8 at 1:31 PM
$PTHS Somehow, I got 6 shares for $18.30 in my account yesterday. I'm not sure how I'm not sure it went that low
0 · Reply
Latest News on PTHS
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

Aug 18, 2025, 8:00 AM EDT - 7 hours ago

Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update

Jwa68
Jwa68 Aug. 15 at 11:10 PM
$PTHS 25, 2025, following an inquest held before the court regarding the Company’s damages, the court entered an order (i) holding that the Company (identified in the order as Chromocell Therapeutics Corporation) is entitled to damages against Mr. Kopfli and Chromocell Corporation, jointly and severally, in the amount of $17,950,205.38, as well as additional damages against Mr. Kopfli in the amount of $348,461, and (ii) directing entry of judgment in the Company’s favor for those amounts, accordingly
0 · Reply
Bigmal1
Bigmal1 Aug. 15 at 1:43 PM
$PTHS PT $50
1 · Reply
Jwa68
Jwa68 Aug. 14 at 1:06 AM
$PTHS They just received an $18M judgement in their favor that dates back long before the merger. Shares are cheap here. 600k float will again soon be found the momentum crowd. Just need a very small spark.
1 · Reply
yourwifesbf69
yourwifesbf69 Aug. 13 at 11:05 PM
$PTHS During the three and six months ended June 30, 2025, the Company had a net loss of approximately $3.5 million and $5.4 million, respectively. As of June 30, 2025, the Company has cash of approximately $0.1 million and a working capital deficit $6.5 million. Based on the Company’s current projections, management believes there is substantial doubt about its ability to continue to operate as a going concern and fund its operations through at least the next twelve months following the issuance of these condensed consolidated financial statements. While the Company completed an equity offering of $50.1 million subsequent to the end of the reporting period, the Company expects that costs associated with the commercial launch of Zelsuvmi ),
1 · Reply
Slapshot22
Slapshot22 Aug. 13 at 10:11 PM
$PTHS Q2 10-Q earnings posted on corp site IR under earnings. Will have to read in depth when not on phone. GLA.
0 · Reply
PBRider
PBRider Aug. 11 at 4:50 PM
$PTHS anyone know when we can expect earnings? Now with first and only product on market, this should soar...
1 · Reply
Zergg
Zergg Aug. 8 at 7:55 PM
$PTHS i think i was early with my last post but i don’t believe im wrong on value. I would put this hitting 100 around Q4 earnings at this point. Once the new product launch is on the wrap sheet.
1 · Reply
Jwa68
Jwa68 Aug. 8 at 7:09 PM
$PTHS Cheap again. Likely good for another trade with the miniscule share coint sub 1m
0 · Reply
DarthGoat
DarthGoat Aug. 8 at 2:02 PM
$CGTX $ELPW $ENGS $PTHS $WOLF You placed orders on July 8 using my EPEC data published on Substack — here’s the profit you could have made as of August 8 by simply placing buy orders after the market opened. To get this link, just email me at [email protected].
0 · Reply
Tgk11
Tgk11 Aug. 8 at 1:31 PM
$PTHS Somehow, I got 6 shares for $18.30 in my account yesterday. I'm not sure how I'm not sure it went that low
0 · Reply
BullishSkull
BullishSkull Aug. 7 at 9:05 PM
$PTHS float size?
0 · Reply
ChartChartist
ChartChartist Aug. 6 at 6:48 PM
$PTHS now they’ll try a bit it seems. Earnings 9/3 and they gotta soak what they can prior. Will see if asks just get bought
0 · Reply
Trade4Profits007
Trade4Profits007 Aug. 6 at 12:22 PM
$PTHS $RGC $SBET 🚨 Microfloat Alert! $PTHS is flying under the radar with HUGE potential. 🧠 Low float + growing volume = breakout brewing? 📈 Eyes on this one before it gets discovered. 💥 Chart shaping up like a classic pre-run setup. Don’t sleep on the next potential runner.
0 · Reply
Bigmal1
Bigmal1 Aug. 5 at 3:54 AM
$CTNT $JFBR $PTHS
0 · Reply
Trade4Profits007
Trade4Profits007 Aug. 4 at 5:37 PM
$PTHS $RGC $VERB $NVDA $PTHS is showing strong potential with a low float and increasing trading volume. Insider activity remains solid, and short interest presents a possible short squeeze opportunity. With just about one day to cover, this microcap biotech is positioned for notable movement. Keep an eye on this name — it could be a compelling addition to your portfolio.
0 · Reply
Trade4Profits007
Trade4Profits007 Aug. 4 at 1:53 PM
$PTHS $RGC $TMC
0 · Reply
Jwa68
Jwa68 Aug. 2 at 6:10 PM
$PTHS Fair value is higher. $25-$28 as it sits. The traders and momentum crowd may again find upon a catalyst where the tiny float could cause another run at new highs in excess of the high $40's.
0 · Reply
ChartChartist
ChartChartist Jul. 31 at 7:46 PM
$PTHS they are sniffing to see if theres sellers.
0 · Reply
Trade4Profits007
Trade4Profits007 Jul. 31 at 4:29 PM
$UNH Make your losses back on $PTHS
0 · Reply
Trade4Profits007
Trade4Profits007 Jul. 31 at 3:28 PM
$RGC Jump over to $PTHS if you are looking for a similar and better play
0 · Reply
Trade4Profits007
Trade4Profits007 Jul. 30 at 2:17 PM
$PTHS Here’s a simple valuation model for Pelthos Therapeutics (PTHS) using scenarios based on potential success of their product ZELSUVMI™, the first FDA-approved at-home treatment for molluscum contagiosum. 🧮 Revenue Scenarios (Year 1-2 of Launch)
0 · Reply
Zergg
Zergg Jul. 28 at 2:22 AM
$PTHS PTHS will hit 100$ in less than a month mark tour calenders
0 · Reply